Tech Company Financing Transactions

C4 Therapeutics Funding Round

C4 Therapeutics, operating out of Watertown, scored $73 million in funding from Cobro Ventures, Cormorant Asset Management and The Kraft Group.

Transaction Overview

Company Name
Announced On
1/8/2016
Transaction Type
Venture Equity
Amount
$73,000,000
Round
Series A
Investors

Cobro Ventures (Lead Investor)

Cormorant Asset Management

The Kraft Group

Proceeds Purpose
The Company is developing novel treatments in the field of targeted protein degradation using proprietary Degronimid technology.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
490 Arsenal Way 200
Watertown, MA 02472
USA
Email Address
Not Recorded
Overview
C4 Therapeutics (Nasdaq: CCCC) is developing a new class of targeted protein degradation (TPD) therapeutics for the treatment of a broad range of diseases.
Profile
C4 Therapeutics LinkedIn Company Profile
Social Media
C4 Therapeutics Company Twitter Account
Company News
C4 Therapeutics News
Facebook
C4 Therapeutics on Facebook
YouTube
C4 Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chairman
Marc Cohen
  Marc Cohen LinkedIn Profile  Marc Cohen Twitter Account  Marc Cohen News  Marc Cohen on Facebook
Chief Financial Officer
William McKee
  William McKee LinkedIn Profile  William McKee Twitter Account  William McKee News  William McKee on Facebook
Chief Medical Officer
Adam Crystal
  Adam Crystal LinkedIn Profile  Adam Crystal Twitter Account  Adam Crystal News  Adam Crystal on Facebook
Chief Scientific Officer
Stew Fisher
  Stew Fisher LinkedIn Profile  Stew Fisher Twitter Account  Stew Fisher News  Stew Fisher on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/8/2016: Razzor venture capital transaction
Next: 1/8/2016: Bottlenose venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary